European Archives - Page 42 of 1128 - European Medical Journal

Early Ozone Exposure Linked to Childhood Asthma Risk

Early exposure to ambient ozone in the first 2 years of life is associated with an increased risk of asthma and wheeze in early childhood.

Patients With Autoimmune Diseases Need Boosters to Prevent COVID-19 Hospitalisation

A new study shows that even during the Omicron era, patients with systemic autoimmune rheumatic diseases face significant risks of hospitalisation due to COVID-19, particularly if unvaccinated or on immunosuppressive therapies.

New Stretchable X-ray Detector Paves Way for Tumour Detection During Surgery

A new study reveals a stretchable X-ray detector that converts radiation into visible light, potentially transforming tumour margin detection during surgery.

Alcohol-Linked Pancreatitis Rates Soar Among Young Women

New data from Ontario reveals a concerning rise in alcohol-related gastrointestinal diseases among people aged 13 to 39, with young women showing the steepest increase.

Neonatal Antibiotics May Weaken Infant Vaccine Response

Early-life exposure to antibiotics may impair immune responses to routine infant vaccinations, according to new research.

Could Certain Gut Bacteria Stunt Growth?

The findings revealed that certain gut bacteria increase short stature risk.

EBMT 2025 Interview: Luigi Naldini and Franco Locatelli

EBMT Interview: Luigi Naldini and Franco Locatelli. In this insightful interview, leading experts in gene therapy, Franco Locatelli and…

Lightening bolt on grey background

New tool supercharges lipid nanoparticle analysis

CloudSpec speeds up lipid nanoparticle analysis, cutting lab times from hours to seconds for gene therapy and vaccine research.

20-Year Study Reveals Keys to Success in Complex Coronary Interventions

PCI for unprotected left main coronary artery shows 70% survival at 5.5 years, according to a 20-year Italian registry of 1,000 patients.

Video Endoscopic Inguinal Lymphadenectomy: A Game Changer in Penile Cancer Surgery?

VEIL outperforms OIL in reducing complications and recovery time in penile cancer surgery, offering notable clinical benefits.